A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL919 in Healthy Participants
Clinical trial NCT05450549 · COMPLETED
Trial details
- NCT number
- NCT05450549
- Sponsor
- Denali Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2023-06-08
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.